slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 224,161-224,190
Pages 10,126
Rows per page 30
Component
224,161-224,190 of 303,780
26
Mainz Biomed NV | Investor Presentation Deck | 27 slidesMainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
27
Mainz Biomed NV | Investor Presentation Deck | 27 slidesMainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
01
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
02
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
03
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Problem1 hit
04
The slide presents preliminary financial results for Matson, including income statement components and debt/cash positions.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
05
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
01
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
02
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
03
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Attention1 hit
05
Includes specific data sources for Hawaii state and Maui economic reports.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
Includes GAAP EPS, depreciation, and EBITDA metrics.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
14
Includes a footnote regarding total debt calculation.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
15
CCF likely refers to Capital Construction Fund.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations 1 hit
16
Matson | Results Presentation Deck | 18 slidesMatson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Action1 hit
18
Includes two separate tables for three-month and nine-month periods.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Action1 hit
01
MaxCyte | Investor Presentation Deck | 19 slidesMaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
02
MaxCyte | Investor Presentation Deck | 19 slidesMaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
03
The slide uses a three-column layout to summarize key value propositions.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
04
The slide uses a dual-track timeline showing the progression of Cell Therapy and Drug Discovery business segments alongside corporate milestones.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
05
The slide uses a process flow diagram to show the funnel from potential partnerships to active clinical programs.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Traction1 hit
06
The chart shows a cumulative growth of partnerships over time from 2017 to 2023.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Traction1 hit
07
Includes a mix of historical data, pipeline metrics, and future projections.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide highlights the transition from RUO to cGMP capabilities across the product line.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide explicitly labels the model as 'Razor/Razor Blade Economics'.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Business Model1 hit
11
Uses the 'Razor/Razor Blade' business model framework.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations Beat · Business Model1 hit
12
The chart uses a timeline-based progression from early clinical to commercial phase.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
13
The chart uses a stacked bar format to distinguish between pre-commercial and commercial revenue components.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit
14
The slide uses donut charts to visualize the distribution of milestone events across IND, Pre-Pivotal, and Pivotal or Later phases.MaxCyte | Investor Presentation Deck | 19 slides · MaxCyte
Pitch deck Investor relations 1 hit